We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+5.1%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$571M
AUM Growth
+$44.4M
Cap. Flow
+$53.7M
Cap. Flow %
9.4%
Top 10 Hldgs %
59.5%
Holding
28
New
2
Increased
16
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$29.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$27M
3
ABT icon
Abbott
ABT
+$18.7M
4
LPNT
LifePoint Health, Inc.
LPNT
+$9.88M
5
MCK icon
McKesson
MCK
+$9.81M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$20.1M
2
SHPG
Shire pic
SHPG
+$13.2M
3
BIIB icon
Biogen
BIIB
+$7.49M
4
LLY icon
Eli Lilly
LLY
+$7.24M
5
EXEL icon
Exelixis
EXEL
+$4.86M

Sector Composition

Rank Sector Weight
1 Healthcare 98.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$60.9M 10.66%
824,450
-90,470
-10% -$7.24M
BAX icon
2
Baxter International
BAX
$11.7B
$51.4M 9%
1,079,233
+290
+0% +$13.7K
ABT icon
3
Abbott
ABT
$175B
$34.8M 6.09%
872,590
+436,390
+100% +$18.7M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$32M 5.6%
608,190
+420,690
+224% +$27M
RVTY icon
5
Revvity
RVTY
$12.3B
$31.9M 5.59%
615,428
+71,718
+13% +$3.91M
IRWD icon
6
Ironwood Pharmaceuticals
IRWD
$635M
$27.8M 4.87%
2,340,894
+228,269
+11% +$2.67M
BSX icon
7
Boston Scientific
BSX
$65.4B
$27.7M 4.84%
1,254,880
-157,290
-11% -$3.75M
GILD icon
8
Gilead Sciences
GILD
$167B
$27M 4.73%
+364,990
New +$29.6M
IART icon
9
Integra LifeSciences
IART
$1.5B
$24M 4.2%
612,414
-46,900
-7% -$1.96M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$123B
$22.4M 3.92%
268,880
-10,203
-4% -$964K
BIO icon
11
Bio-Rad Laboratories Class A
BIO
$8.15B
$22.4M 3.91%
132,584
+3,460
+3% +$525K
MASI
12
DELISTED
Masimo
MASI
$21.5M 3.77%
356,223
+4,170
+1% +$235K
BIIB icon
13
Biogen
BIIB
$30.4B
$21.1M 3.7%
71,400
-25,290
-26% -$7.49M
EXEL icon
14
Exelixis
EXEL
$14.1B
$19.9M 3.48%
1,610,491
-449,342
-22% -$4.86M
MRK icon
15
Merck
MRK
$315B
$19.1M 3.34%
333,274
+73,737
+28% +$4.31M
MCK icon
16
McKesson
MCK
$98.5B
$17.7M 3.1%
131,660
+52,640
+67% +$9.81M
PDCO
17
DELISTED
Patterson Companies, Inc.
PDCO
$16.1M 2.83%
345,792
-71,052
-17% -$3.36M
ELV icon
18
Elevance Health
ELV
$80.9B
$15.2M 2.66%
122,850
+18,550
+18% +$2.4M
SHPG
19
DELISTED
Shire pic
SHPG
$14.2M 2.49%
84,461
-67,925
-45% -$13.2M
CI icon
20
Cigna
CI
$74.5B
$14.1M 2.48%
112,070
+2,200
+2% +$287K
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$10.6M 1.86%
958,879
+43,900
+5% +$516K
UTHR icon
22
United Therapeutics
UTHR
$22.7B
$9.98M 1.75%
83,474
+2,250
+3% +$270K
LPNT
23
DELISTED
LifePoint Health, Inc.
LPNT
$9.97M 1.75%
+164,714
New +$9.88M
IPXL
24
DELISTED
Impax Laboratories, Inc.
IPXL
$7.32M 1.28%
409,964
+176,030
+75% +$4.73M
ACH
25
Accendra Health
ACH
$266M
$6.75M 1.18%
211,172
+8,830
+4% +$309K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2016 Portfolio in Review

As of Q3 2016, Sector Gamma AS held 28 positions worth $571M, up 8.4% from $527M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Sector Gamma AS deployed $53.7M of net new capital in Q3 2016, opening 2 new positions and adding to 16 existing holdings. Its largest new stake was Gilead Sciences: 364,990 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was Shire pic, an estimated $13.2M trimmed.

  • Sector Gamma AS's largest Q3 2016 buy was Gilead Sciences: 364,990 shares worth $27M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q3 2016, an estimated $27M increase.
  • Sector Gamma AS's biggest Q3 2016 reduction was Shire pic, cutting an estimated $13.2M.
  • Sector Gamma AS fully exited St Jude Medical in Q3 2016, selling an estimated $20.1M.
  • Sector Gamma AS's ten largest holdings make up 59% of its $571M portfolio in Q3 2016.
  • Sector Gamma AS opened 2 new positions and closed 1 in Q3 2016.
  • Sector Gamma AS's portfolio value rose 8.4% quarter-over-quarter to $571M.

Based on Sector Gamma AS's 13F filing for Q3 2016, filed 8 Nov 2016.